ARDX Ardelyx Inc
Price (delayed)
$5.06
Market cap
$1.21B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.17
Enterprise value
$1.29B
Ardelyx is focused on discovering, developing, and commercializing innovative first-in-class medicines to enhance the lives of patients with kidney and cardiorenal diseases. Ardelyx is advancing tenapanor, a novel product candidate
Highlights
The company's revenue has surged by 168% YoY and by 32% QoQ
The company's gross profit has surged by 165% YoY and by 32% QoQ
The company's quick ratio rose by 14% QoQ but it fell by 3.4% YoY
Ardelyx's debt has surged by 174% YoY and by 47% QoQ
Key stats
What are the main financial stats of ARDX
Market
Valuations
Earnings
Shares outstanding
238.36M
Market cap
$1.21B
Enterprise value
$1.29B
Price to earnings (P/E)
N/A
Price to book (P/B)
6.92
Price to sales (P/S)
3.57
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.88
Revenue
$333.62M
Gross profit
$283.06M
Operating income
-$27.95M
Net income
-$39.14M
EBIT
-$25.86M
EBITDA
-$19.79M
Free cash flow
-$45.82M
Per share
Balance sheet
Liquidity
EPS
-$0.17
EPS diluted
-$0.17
Free cash flow per share
-$0.19
Book value per share
$0.73
Revenue per share
$1.42
TBVPS
$1.85
Total assets
$435.75M
Total liabilities
$262.47M
Debt
$153.44M
Equity
$173.29M
Working capital
$278.62M
Debt to equity
0.89
Current ratio
4.58
Quick ratio
3.95
Net debt/EBITDA
-4.47
Margins
Efficiency
Dividend
EBITDA margin
-5.9%
Gross margin
84.8%
Net margin
-11.7%
Operating margin
-8.4%
Return on assets
-10.5%
Return on equity
-24.9%
Return on invested capital
-6.9%
Return on capital employed
-7.2%
Return on sales
-7.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ARDX stock price
How has the Ardelyx stock price performed over time
Intraday
-11.54%
1 week
-12.61%
1 month
3.05%
1 year
-40.47%
YTD
-0.2%
QTD
-0.2%
Financial performance
How have Ardelyx's revenue and profit performed over time
Revenue
$333.62M
Gross profit
$283.06M
Operating income
-$27.95M
Net income
-$39.14M
Gross margin
84.8%
Net margin
-11.7%
The company's revenue has surged by 168% YoY and by 32% QoQ
The company's gross profit has surged by 165% YoY and by 32% QoQ
ARDX's operating margin has surged by 83% year-on-year and by 67% since the previous quarter
Ardelyx's net margin has surged by 78% YoY and by 59% QoQ
Growth
What is Ardelyx's growth rate over time
Valuation
What is Ardelyx stock price valuation
P/E
N/A
P/B
6.92
P/S
3.57
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.88
The EPS has increased by 45% since the previous quarter and by 43% year-on-year
ARDX's P/B is 31% below its last 4 quarters average of 10.1 but 26% above its 5-year quarterly average of 5.5
Ardelyx's equity has increased by 9% QoQ and by 3.9% YoY
The company's revenue has surged by 168% YoY and by 32% QoQ
The price to sales (P/S) is 88% lower than the 5-year quarterly average of 28.8 and 50% lower than the last 4 quarters average of 7.2
Efficiency
How efficient is Ardelyx business performance
The return on sales has surged by 84% year-on-year and by 68% since the previous quarter
The company's return on invested capital has surged by 78% YoY and by 63% QoQ
Ardelyx's ROA has soared by 60% YoY and by 51% from the previous quarter
Ardelyx's ROE has increased by 47% from the previous quarter and by 43% YoY
Dividends
What is ARDX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ARDX.
Financial health
How did Ardelyx financials performed over time
ARDX's total assets is 66% greater than its total liabilities
ARDX's total liabilities has surged by 101% year-on-year and by 25% since the previous quarter
ARDX's total assets is up by 46% year-on-year and by 18% since the previous quarter
Ardelyx's debt is 11% lower than its equity
Ardelyx's debt has surged by 174% YoY and by 47% QoQ
Ardelyx's debt to equity has surged by 162% YoY and by 35% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.